This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2016-2021.
Company Filing History:
Years Active: 2016-2021
Title: Marion Goldeck: Innovator in RIG-I Ligands
Introduction
Marion Goldeck is a prominent inventor based in Bonn, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of RIG-I ligands. With a total of 5 patents to her name, her work has implications for pharmaceutical applications.
Latest Patents
One of her latest patents focuses on RIG-I ligands and methods for producing them. This invention relates to new triphosphate-modified oligonucleotides that may act as RIG-I ligands. Additionally, it introduces a new method that allows for the synthesis and purification of these oligonucleotides in high yield and purity, making them suitable for pharmaceutical applications.
Career Highlights
Marion Goldeck is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where she conducts her research and development. Her innovative work has positioned her as a key figure in her field, contributing to advancements in molecular biology and therapeutic applications.
Collaborations
Throughout her career, Marion has collaborated with notable colleagues, including Jasper Van Den Boorn and János Ludwig. These partnerships have enhanced her research efforts and expanded the impact of her inventions.
Conclusion
Marion Goldeck's contributions to the field of biochemistry, particularly through her patents on RIG-I ligands, highlight her role as an influential inventor. Her work continues to pave the way for advancements in pharmaceutical applications.